J&J Recalls Infant Tylenol Over Dosing System Flaw
The recall is the latest in a long series for J&J’s consumer division involving Tylenol and other over-the-counter brands for adults and children.
No adverse events have been reported in association with Friday’s Tylenol recall, J&J said.
Copyright 2024 Reuters. Click for restrictions.
Popular Today
- Swiss Re: Mitigating Flood Risk 10x More Cost Effective Than Rebuilding
- Verisk: A Shift to More EVs on The Road Could Have Far-Reaching Impacts
- PE Firm Cornell Sued Over $345 Million Instant Brands Dividend
- T-Mobile’s Network Breached as Part of Chinese Hacking Operation
Popular This Month